CME Group Inc. (NASDAQ:CME) Shares Sold by Headlands Technologies LLC

Headlands Technologies LLC trimmed its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 7.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 19,660 shares of the financial services provider’s stock after selling 1,583 shares during the period. Headlands Technologies LLC’s holdings in CME Group were worth $4,566,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in CME. SJS Investment Consulting Inc. boosted its stake in CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 97 shares during the last quarter. Dunhill Financial LLC raised its stake in shares of CME Group by 188.4% in the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares in the last quarter. New Age Alpha Advisors LLC lifted its position in shares of CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 43 shares during the last quarter. Financial Life Planners acquired a new position in CME Group in the fourth quarter worth about $32,000. Finally, Knuff & Co LLC acquired a new stake in CME Group during the fourth quarter valued at approximately $33,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on CME shares. Erste Group Bank raised shares of CME Group to a “strong-buy” rating in a report on Monday, March 17th. JPMorgan Chase & Co. upped their target price on CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a report on Thursday, February 13th. Morgan Stanley raised their price target on CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 19th. Piper Sandler upped their price objective on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. Finally, Citigroup cut CME Group from a “buy” rating to a “neutral” rating and cut their target price for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, CME Group presently has an average rating of “Hold” and an average price target of $238.93.

Check Out Our Latest Report on CME Group

CME Group Stock Performance

Shares of NASDAQ CME opened at $265.29 on Tuesday. The stock has a fifty day moving average price of $250.30 and a two-hundred day moving average price of $236.21. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $267.91. The firm has a market cap of $95.60 billion, a P/E ratio of 27.43, a PEG ratio of 6.76 and a beta of 0.53. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.88%. This is a boost from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend was Friday, March 7th. CME Group’s payout ratio is presently 51.71%.

CME Group declared that its board has authorized a stock repurchase plan on Thursday, December 5th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to purchase up to 3.4% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its shares are undervalued.

Insider Transactions at CME Group

In other news, insider Julie Winkler sold 11,592 shares of the business’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the sale, the insider now owns 21,885 shares in the company, valued at $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the sale, the chief operating officer now owns 8,036 shares of the company’s stock, valued at approximately $2,063,885.88. This trade represents a 15.73 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,076 shares of company stock valued at $6,871,496 over the last three months. Company insiders own 0.30% of the company’s stock.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.